IPO registrations (S-1, F-1) · Registrants
CardioVascular BioTherapeutics, Inc.
- SEC CIK
- 1303497 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2004-09-23, last 2007-06-26; 2 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2005-02-15; declared effective 2006-06-12
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1930 VILLAGE CENTER CIRCLE, #3-625, Las Vegas, NV 89134
- EIN
- 33-0795984
- EDGAR entity type
- operating
- Insiders and CEO pay
- CardioVascular BioTherapeutics, Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2005-02-15, an initial public offering)
- Shares sold
- 1,500,000
- Gross proceeds
- $15,000,000 before underwriting discounts and any over-allotment option
- Lead underwriters
- First Dunbar Securities Corporation
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: CARDIOVASCULAR BIOTHERAPEUTICS EXACT (EIN (EXACT))
- Form D issuer: CardioVascular BioTherapeutics, Inc. EXACT (CIK (EXACT))
- SEC filer: CardioVascular BioTherapeutics, Inc. EXACT (CIK (EXACT))
Filings 11
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2004-09-23 | S-1 | S-1 (registration) | CardioVascular BioTherapeutics, Inc. | 0001193125-04-160371 ↗ |
| 2004-11-26 | S-1/A | S-1/A (amendment) | CardioVascular BioTherapeutics, Inc. | 0001193125-04-203664 ↗ |
| 2005-01-13 | S-1/A | S-1/A (amendment) | CardioVascular BioTherapeutics, Inc. | 0001193125-05-005540 ↗ |
| 2005-01-31 | S-1/A | S-1/A (amendment) | CardioVascular BioTherapeutics, Inc. | 0001193125-05-015485 ↗ |
| 2005-02-04 | S-1/A | S-1/A (amendment) | CardioVascular BioTherapeutics, Inc. | 0001193125-05-020003 ↗ |
| 2005-02-10 | S-1/A | S-1/A (amendment) | CardioVascular BioTherapeutics, Inc. | 0001193125-05-025293 ↗ |
| 2005-02-15 | 424B4 | 424B4 (final prospectus) | CardioVascular BioTherapeutics, Inc. | 0001193125-05-030392 ↗ |
| 2006-06-12 | EFFECT | EFFECT (declared effective) | CardioVascular BioTherapeutics, Inc. | 9999999995-06-000281 ↗ |
| 2007-04-19 | S-1 | S-1 (registration) | CardioVascular BioTherapeutics, Inc. | 0001193125-07-085327 ↗ |
| 2007-06-26 | S-1/A | S-1/A (amendment) | CardioVascular BioTherapeutics, Inc. | 0001193125-07-143120 ↗ |
| 2007-06-28 | EFFECT | EFFECT (declared effective) | CardioVascular BioTherapeutics, Inc. | 9999999995-07-002603 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2005-02-10 | S-1/A | registration statement | $10.00 | 1,500,000 | $15,000,000 | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ | ||
| 2005-02-15 | 424B4 | final prospectus | $10.00 | 1,500,000 | $15,000,000 | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| MONTANO DANIEL C | Director,Officer,TenPercentOwner | CEO, President, and Chairman; Chairman, CEO & President; Chairman, President & CEO; Chairman, President, CEO; Co-President, CEO & ChaimanBOD; President, CEO & Chairman BOD | 9 | 2006 | |
| Stegmann Thomas | Director,Officer,TenPercentOwner; TenPercentOwner | Chief Clincial Officer; Chief Clinical Officer; Chief Medical Officer; Co-President & CCO | 21 | 2006–2009 | |
| CardioVascular BioTherapeutics, Inc. | Director,Officer,TenPercentOwner | VP & Chief Clinical Officer | 1 | 2006 | |
| Jacobs John W | Director,Officer | Chief Operating Officer & CSO; Chief Scientific Officer; COO and Vice President; COO & Vice President; CSO, COO and Vice President | 14 | 2006–2008 | |
| Thomas Kenneth JR | Officer | Vice President R & D; V.P. of Research & Development | 2 | 2006 | |
| COOPER C K & CO INC /FA/ | DirectorOther | 1 | 2006 | ||
| Flaa Mickael | Director,Officer | Chief Financial Officer; Chief Financial Officer & VP; V.P. & CFO | 3 | 2006–2008 | |
| C & K Capital CORP | DirectorOther | 2 | 2006 | ||
| Paladin Capital Management | Director; DirectorOther | 3 | 2006 | ||
| Montano Alexander Gene | Director | 9 | 2006 | ||
| ABROMOVITZ GARY B | Director | 3 | 2006–2007 | ||
| Baik Joong-Ki | Director; Director,TenPercentOwner | 2 | 2006–2007 | ||
| Gordon Grant | Director; Director,TenPercentOwner | 4 | 2006–2007 | ||
| HORN SETH A | Officer; Other | Corporate Controller & VP | 4 | 2006–2007 | |
| Ingram Thomas | Director | 2 | 2006–2007 | ||
| Levin Robert S | Director | 12 | 2006–2008 | ||
| Pelton Judith S | Officer | Corporate Secretary | 2 | 2006–2008 | |
| Priemer Wolfgang | Director; Director,TenPercentOwner | 30 | 2006–2008 | ||
| ROTH VINCENT J | Officer | General Counsel & VP | 3 | 2006–2007 | |
| Chanson Frederic | Director | 1 | 2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2015-01-14 | CardioVascular BioTherapeutics, Inc. | Biotechnology | $49,000,000 | $0 | 0 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | CARDIOVASCULAR BIOTHERAPEUTICS | NV | Form 5500 (employee benefit plans) | name and state |
| Form D issuer | CardioVascular BioTherapeutics, Inc. | NV | Form D private offerings | CIK (EXACT) |
| Patent assignee | CardioVascular BioTherapeutics, Inc. | NV | Patents (USPTO) | name and state |
| SEC filer | CardioVascular BioTherapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | CARDIOVASCULAR BIOTHERAPEUTICS | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NV first:
- SKINVISIBLE, INC. NV
- Praxsyn Corp NV
- EnzymeBioSystems NV
- CQENS Technologies Inc. NV
- BIOADAPTIVES, INC. NV
- BIOVIE INC. NV
- Mystic Holdings Inc./NV NV
- Option Therapeutics Inc. NV
- PHARMOS CORP NV
- SPECTRUM PHARMACEUTICALS INC NV
In other datasets, the same topic (Health) in NV:
- Nonprofit: ACTIVSTEM FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health